XML 54 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Income taxes (Tables)
12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign

The loss from operations before tax (expense) benefit consisted of the following for the years ended December 31, 2020, 2019, and 2018:

    

2020

    

2019

    

2018

Domestic

$

(452,475)

$

(231,915)

$

(68,461)

Foreign

 

49,543

 

(8,011)

 

(59,649)

Total

$

(402,932)

$

(239,926)

$

(128,110)

Components of Income Tax Provision

The Income Tax Provision consisted of the following for the years ended December 31, 2020, 2019 and 2018:

    

2020

    

2019

    

2018

Current:

 

  

 

  

 

  

U.S. Federal

$

$

$

U.S. State and Local

 

(24,984)

 

(61)

 

(38)

Foreign

 

(4,372)

 

(2,041)

 

(669)

Deferred:

 

  

 

  

 

  

U.S. Federal

 

 

 

U.S. State and Local

 

(5,872)

 

(8,812)

 

Foreign

 

 

(736)

 

736

Total tax benefit (expense)

$

(35,228)

$

(11,650)

$

29

Schedule of reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate

A reconciliation of the U.S. statutory income tax rate to the Company’s effective tax rate is as follows:

    

December 31, 

 

    

2020

    

2019

    

2018

 

Federal income tax provision at statutory rate

21.00

%  

21.00

%  

21.00

%

State income tax provision, net of federal benefit

(3.31)

 

1.08

 

0.05

Permanent differences

(6.66)

 

(6.17)

 

(6.41)

Research and development

4.93

 

4.38

 

6.49

Change in valuation allowances

(26.40)

 

(35.49)

 

2.20

Change in deferred tax assets

2.93

 

15.89

 

(14.22)

Foreign tax rate differential

0.72

 

(1.88)

 

(9.10)

Tax rate change

(1.46)

 

(3.67)

 

(Accrual) Release of uncertain tax positions

(0.61)

Other

0.12

 

 

0.01

Effective income tax rate

(8.74)

%  

(4.86)

%  

0.02

%

Schedule of significant components of the Company's deferred tax assets and liabilities The amount of deferred income taxes are as follows:

The significant components of the Company’s deferred tax assets and liabilities at December 31, 2020 and 2019 are as follows:

    

2020

    

2019

Deferred tax assets:

 

  

 

  

Accrued expense

$

5,528

$

2,588

Amortization

 

80,677

 

78,291

Depreciation

 

 

991

Federal tax credits

 

123,405

 

99,421

State tax credits

 

 

6,489

Federal net operating losses

 

16,999

 

91,010

State net operating losses

 

1,428

 

1,360

Foreign net operating losses

 

 

1,056

Capitalized research and development costs

 

661

 

1,274

Share based compensation and other

 

14,612

 

16,425

Liability for sale of future royalties

161,204

Other comprehensive loss

 

7,624

 

1,512

Total gross deferred tax assets

 

412,138

 

300,417

Less valuation allowance

 

(379,608)

 

(267,131)

Total deferred tax assets, net of valuation allowance

$

32,530

$

33,286

Deferred tax liabilities:

 

  

 

  

Depreciation

$

(2,904)

$

Convertible debt

(29,626)

(33,286)

Indefinite lived intangible

 

(136,735)

 

(130,862)

Total gross deferred tax liabilities

 

(169,265)

 

(164,148)

Net deferred tax assets (liabilities)

$

(136,735)

$

(130,862)

Schedule of uncertain income tax benefits

A reconciliation of the gross amount of unrecognized tax benefits, excluding accrued interest and penalties, is as follows:

Unrecognized Tax Benefits

Balance at December 31, 2019

Increase in tax positions for prior years

 

2,446

Balance at December 31, 2020

$

2,446